FDA to Push for Price Disclosures in Drug Advertisements (1)

May 11, 2018, 7:05 PM; Updated: May 11, 2018, 10:12 PM

Drugmakers will soon have to disclose the list price of their products in ads if the Food and Drug Administration gets its way.

Alex Azar, secretary of health and human services, said FDA Commissioner Scott Gottlieb will be prioritizing drug marketing in the coming weeks. “Why not have drug companies disclose their prices in ads?” Azar asked a crowd of administration officials and journalists at President Donald Trump’s drug pricing speech May 11. We’re going to have the FDA “looking into that,” he said.

The FDA is currently “forming a new working group to look at modernizing approaches to direct-to-consumer ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.